Tech Company Financing Transactions
NeuroTherapeutics Pharma Funding Round
Thomas, McNerny & Partners and private investors participated in a $1 million capital raise for NeuroTherapeutics Pharma. This venture round closed on 3/31/2008.
Transaction Overview
Company Name
Announced On
3/31/2008
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Investors
Thomas, McNerny & Partners (James Thomas)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
8750 West Bryn Mawr Avenue 440
Chicago, IL 60631
USA
Chicago, IL 60631
USA
Phone
Website
Email Address
Overview
NeuroTherapeutics Pharma (NTP) is an early stage company focused on the development of therapies for CNS disorders with an initial focus on epilepsy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Collins
Chief Scientific Officer
Michael Venuti
VP - Finance
Brian Williams
VP - Operations
Holli Carlson
VP - R & D
Stephen Wanaski
Browse more venture capital transactions:
Prev: 3/31/2008: Storage Genetics venture capital transaction
Next: 3/31/2008: Otologics venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs